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Calcium in Renal Cells. Modulation of
Calcium-Dependent Activation of
Phospholipase A2
by Joseph V. Bonventre*
Calcium has been implicated as a regulatory factor in many physiological and pathophysiologi-
cal processes in the renal cell. Under physiological conditions, the cytosolic free calcium concen-
tration is maintained at approximately 100 nM. Most of the releasable cell Ca2' resides in the
nonmitochondrial compartments. In addition to the plasma membrane Ca2+ transport processes,
there is a high-affinity, low-capacity buffering capability of nonmitochondrial organelles and a
lower-affinity high-capacity mitochondrial Ca2+ buffering capability.
A critical enzymatic effector of Ca2' action in the cell is phospholipase A2. By using digitonin-
permeabilized renal mesangial cells, the[Ca2+1 dependency ofphospholipase A2 was characterized.
The [Ca2+] sensitivity was insufficient to explain the phospholipase A2 activation observed with
vasopressin. In both intact cells, as well as permeabilized cells, it was found that protein kinase C
activation markedly enhanced the Ca2' calmodulin-dependent activation of phospholipase A2.
In response to platelet-derived growth factor, it was found that arachidonic acid release pre-
ceded phospholipase C activation. This suggests that other effectors besides Ca2+ and protein
kinase C may also be important for phospholipase A2 activation.
In an experimental model designed to mimic postischemic reperfusion damage to renal mito-
chondria, it was demonstrated that reactive oxygen species act synergistically with Ca21 to acti-
vate mitochondriAl phospholipase A2, which mediates damage to site I of the electron transport
chain, the FyFQ ATPase, and the adenine nucleotide translocase.
In conclusioip, an a4equate understanding of the physiological and pathophysiological roles of
intracellular Ca + relies, not only on the measurement of Ca2+ concentration and the characteriza-
tion of "Ca2'-dependent" processes, but an appreciation of the complex synergistic interactions
between Ca2+ and other mediators of cellular activation and toxicity.
Cytosolic Ca2+ Concentration and
Ca2+ Homeostasis
Calcium has been implicated in a number of physio-
logical and pathophysiological processes in the renal
cell. By using three different techniques for measur-
ing cytosolic free Ca2+ concentration ([Ca2']f), Quin 2,
Fura-2 and the null point titration method, we found
[Ca2']f to be approximately 100 nM in cultured renal
epithelial cells (LLC-PK1) and cultured mesangial
cells (1,2).
Regulation of [Ca2']f at these low levels depends on
the functioning of membrane transport systems. At
the plasma membrane the Ca2` ATPase and, likely, a
Na+/Ca2' exchanger (1) function to transport Ca2+ out
of the cell. In the LLC-PK1 we have found that, under
basal conditions, only a small amount (approximately
10%) of releasable Ca2+ resides in the mitochondrial
compartment. In the presence of physiological levels
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of Mg2" and ATP, small amounts of Ca2" added to
digitonin-permeabilized cells are taken up via a vana-
date-inhibitable, ruthenium red-insensitive process
into a nonmitochondrial compartment (3). This com-
partment buffers Ca2" such that [Ca2"]f is maintained
in the 50 to 300 nM range. Thus, under physiological
conditions, most of the cell Ca2" stored in membrane-
bound releasable form is located in a nonmitochon-
drial compartment that may be the endoplasmic
reticulum, a subcompartment of the endoplasmic
reticulum, or other organelles (4). The Ca2" transport
characteristics of this compartment are likely to be
important for the maintenance of cytosolic Ca2" con-
centrations close to basal levels, in spite of minor
fluctuations in plasma membrane transport or per-
meability characteristics. With the continued addi-
tion of Ca2" to permeabilized cells, this compartment
is saturated with Ca2', and the additional Ca2" is buf-
fered by the mitochondria, a high-capacity Ca2" buf-
fering compartment. While mitochondria can take up
very large amounts of Ca2", the resultant free
extramitochondrial Ca2" concentration is in the 600 toJ. V. BONVENTRE
1500 nM range. Thus, when large amounts of Ca2l are
presented to the cell, as when the cell is exposed to a
toxic or ischemic influence, the nonmitochondrial
stores are rapidly saturated, and the mitochondria
assume the primary role of Ca2" buffer (3).
Physiological and Pathophysiological
Roles of Phospholipase A2
One of the effector enzymes that serves as a critical
transducer of Ca2" action in the cell is phospholipase
A2. This enzyme cleaves the fatty acid from the sn-2
position of phospholipids. Since many cellular
phospholipids are enriched in arachidonic acid in the
sn-2 position, phospholipase A2 activation results in
enhanced levels of free arachidonic acid, which is the
precursor for an entire family of metabolically active
substances: prostaglandins, leukotrienes, Hete's,
epoxides, and thomboxanes.
It is believed by most, but not all, investigators that
the production of free arachidonic acid is rate limit-
ing for synthesis of these compounds, thus placing
phospholipase A2 at the critical regulatory step. With
the exception of phospholipase A2 of lysosomal origin,
most of the phospholipase A2 enzymes characterized
to this point require Ca' for activation (5).
Free arachidonic acid and its products may serve as
intracellular messengers (6) and may activate other
phospholipases involved in the signal cascade modu-
lating the cellular responses to activating stimuli. In
addition to these effects on signal transduction, many
of the results of phospholipase A2 activation may be
manifested on other cells in the tissue of origin or
other tissues in the organism since many of the
arachidonic acid cascade products are secreted (7,8).
In addition to the physiological regulatory effects
of phospholipase A2 activation products, there are
many potential adverse consequences to the cell and
organism (9). For example, prostaglandins, leuko-
trienes, and thromboxanes are mediators of inflam-
mation (10). Also, the free fatty acids (11-15) and
lysophospholipids (16) that result from phospholipase
A2-induced phospholipid hydrolysis are very toxic to
the cell. The mitochondria are important targets of
phospholipase A2 action, resulting in adverse conse-
quences to the cell. Activation of mitochondrial
phospholipase A2 results in hydrolysis of cardiolipin
(diphosphatidylglycerol), a lipid that is a critical com-
ponent of the catalytic subunits of the electron trans-
port chain (complexes I, III, and cytochrome oxidase)
(17), ATP synthase (18,19), and adenine nucleotide
translocase (20). Cone-shaped lipids, such as cardi-
olipin, may increase the susceptibility of other mem-
brane phospholipids to phospholipase A2 action by
decreasing the packing of polar head groups (21).
Therefore, because of the implications for under-
standing the physiological response of cells to activat-
ing stimuli and the need to understand the events
triggering cell and tissue injury, it is important to
understand the regulation of phospholipase A2 and
the role played by Ca2" in its activation.
Ca2+-Dependent Activation of
Phospholipase A2
A standard model for cell activation by an agonist,
such as vasopressin resulting in phospholipase A2
activation, can be described as follows: Hormone-
receptor interaction results in the activation of
phospholipase C. This process is mediated by a gua-
nine nucleotide-binding protein in many cells, includ-
ing the mesangial cell (22). The action of
phospholipase C on polyphosphoinositides results in
the generation of inositol trisphosphate (1P3) and dia-
cylglycerol. IP3 acts upon nonmitochondrial Ca2` stor-
age sites to release Ca2+, increasing [Ca2+]f. The
increase in [Ca2+]f results in the activation of
phospholipase A2 and the subsequent generation of
eicosanoids.
We have examined the Ca2'-dependent regulation
of phospholipase A2 in the glomerular mesangial cells
in culture. These cells contract, produce eicosanoids,
proliferate in conditions of disease, and produce
matrix components that may be important in the
pathophysiology of renal disease. When vasopressin
activates mesangial cells, [Ca21]f increases to levels of
approximately 600 nM (2). This increase in [Ca2+]f is
due primarily to its release from intracellular storage
sites, since the reduction of extracellular [Ca2+] with
EGTA only modulates the response minimally. There
is an associated 10-fold increase in prostaglandin E2
production by these cells that is not affected by
changing extracellular [Ca2+] over three ranges (< 100
nM, 1-10 gM, 1.5 mM) (22). This insensitivity of pros-
taglandin synthesis to extracellular [Ca2'] is consis-
tent with the view that release of Ca21 from
intracellular stores, rather than entry of Ca2+ across
the plasma membrane, may be responsible for the
prostaglandin E2 production.
The level of the Ca2+ concentration necessary to
stimulate phospholipase A2 in many assay systems,
however, is significantly higher than that achieved
with hormone activation (22,23). Likewise, under con-
ditions of ischemic and toxic injury, [Ca2+]f increases
to levels lower than those predicted to be necessary to
activate the enzyme in vitro, although damage has
occurred to the cell that has been proposed to be
phospholipase A2 related (24,25).
It is possible that these apparent inconsistencies
between the Ca21 concentrations necessary to activate
the enzyme in cell-free systems and the levels
achieved in the intact cell may be due to the absence
of important cofactors or the enhanced expression of
endogenous inhibitor activity in the assay system in
vitro (26). Alternatively, other modulatory factors
that are present in the intact cell upon activation but
absent in the cell-free system may account for the
differences.
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FIGURE 1. Prostaglandin E2 (PGE2) production as a function of free
Ca21 concentration in digitonin-permeabilized renal mesangial
cells. Media PGE2 content was determined by radioimmunoas-
say 10 min after addition of digitonin. Each data point repre-
sents the mean ± SE of 4 to 10 experiments. Modified from
Bonventre and Swidler (22).
In order to address this issue, we examined the Ca2+
dependency of phospholipase A2 activity under experi-
mental conditions designed to maintain the enzyme in
its normal configuration in the cell. PGE2 synthesis
was measured as a function of cytosolic [Ca2"] in cells
rendered permeable with digitonin. [Ca2+] was
clamped secondary to the large amount of incubation
media relative to cell mass and the free communica-
tion between the cytosolic compartment and bath.
[Ca2"] was measured with a Ca2' electrode (2). When
[Ca2+] varied over the range from < 100 nM to 100 gM,
there was a progressive increase in PGE2 production
(Fig. 1). The increase was modest, but nevertheless
apparent over the physiological range (100 nM-2 gM).
Calmodulin inhibitors (22,27) decreased PGE2 synthe-
sis at all concentrations of [Ca2+]. The addition of
exogenous calmodulin had no effect on PGE2 produc-
tion at any level of[Ca2"], presumably because the cell
permeabilization procedure did not result in loss of
calmodulin in sufficient quantities to compromise
phospholipase A2 function (22).
To establish that the increase in PGE2 production
was associated with an increase in acylhydrolase
activity, arachidonic acid release was measured in
cells prelabeled with 3H-arachidonic acid. Release was
determined as a function of Ca2+ with [Ca2+] fixed at
three different levels (< 100 nM, 1-10 gM, and 500
gM) in digitonin-permeabilized cells. As depicted in
Table 1, free arachidonic acid increased as a function
of Ca2' concentration in a manner that paralleled the
PGE2 production. In addition, 3H-diglyceride levels
were increased with increasing [Ca2+]. This latter
finding of increases in diacylglycerol with increasing
Table 1. Free 3H-arachidonic acid and 3H-diglyceride in
digitonin-treated cells as a function of [Ca2+"].
% Total radioactivity
Ca2" concentration 3H-Arachidonic acid 3H-Diglyceride
< 100 nM 1.7 ± 0.3 0.7 ± 0.1
1-10 giM 5.4 ± 1.9 1.6 ± 0.4
500 ,uM 14.9 ± 7.0 2.5 ± 0.5
aCells were prelabeled with 3H-arachidonic acid. They were then
permeabilized with digitonin in the presence of three different
ranges of calcium concentration. After 10 min cells and superna-
tant were combined and assayed for free 3H-arachidonate and 3H-
diglyceride by thin-layer chromatography after chloroform-metha-
nol extraction (22). Results represent the mean ± SEM of four
experiments. Each value of 3H-arachidonic acid and 3H-diglyceride
was statistically different from values obtained at different [Ca21]
ranges (p < 0.05) (22). Data and table from Bonventre and Swidler
(22).
Ca2+ concentration indicates that phospholipase C
activity in the mesangial cell is sensitive to Ca2+. W-7
(50 gM), a calmodulin inhibitor (28), inhibited the
arachidonic acid release. Furthermore, the
phospholipase A2 inhibitors, dibucaine and
mepacrine, inhibited the Ca2+-dependent arachidonic
acid release, but they had no effect on the Ca2+-depen-
dent increases in 3H-diglyceride (22).
In summary, these observations are consistent with
a Ca21, calmodulin-dependent activation of
phospholipase A2. While these data indicate that
phospholipase A2 can be activated when [Ca2+] is
varied over the physiological range, the degree of
activation is not very great. When the stimulation of
PGE2 production (in response to vasopressin) is com-
pared to that observed in permeabilized cells (in
response to Ca2' concentration increases to levels seen
in vasopressin-stimulated intact cells), it is clear that
the increase in [Ca21]f, observed with vasopressin, is
insufficient to explain the PGE2 production seen with
vasopressin (Fig. 2).
Protein Kinase C Enhancement of
Ca2+-Dependent Phospholipase A2
Activity and PGE2 Production
As indicated previously, when vasopressin and
other agonists stimulate phospholipase C, there is a
resultant increase in protein kinase C activation
along with the rise in [Ca2']f. We examined whether
or not protein kinase C activation modulates the cal-
cium dependency of phospholipase A2 stimulation.
PGE2 production in permeabilized cells was compared
in the presence or absence of PMA when [Ca2+]f was
fixed either at basal levels (< 200 nM) or in the
approximate range achieved in vasopressin-stimu-
lated cells (between 0.3 and 2.2 gM). When Ca2` was
fixed at basal levels, there was no effect of PMA on
PGE2 synthesis.
By contrast, however, when Ca2+ was fixed at the
higher levels in order to mimic the levels of [Ca2+]f
157J. V. BONVENTRE
2500r
2000
. 1500
1000
500
I'
PERMEAO/LIZED CELLS
PDMAtwlJ
PMA
INTACT CELLS
(vasopress.n)
12r
10
H Q.
N
-j %
Z§tf
FIGURE 2. Prostaglandin E2 (PGE2) production in renal mesangial
cells made permeable with digitonin in the presence of0.3 to 2.2
jM [Ca21] with or without simultaneous stimulation with
phorbol myristate acetate (PMA, 300 nM). For comparison, the
PGE2 production from nonpermeabilized intact cells stimulated
with vasopressin (100 nM) is presented. The intact cells were
stimulated in the presence ofthree different ranges of extracel-
lular [Ca2"]. Asterisk (*) denotes (p < 0.001) significantly differ-
ent from control compared with other conditions. Modified
from Bonventre and Swidler (22).
reached with vasopressin, PMA resulted in an
approximate 100% increase in PGE2 production over
that seen with Ca2' alone (22). This increase induced
by PMA resulted in a net PGE2 production in the
permeabilized cell that roughly equaled that in the
vasopressin-stimulated intact cell (Fig. 2).
To further demonstrate that the increase in cal-
cium concentration was necessary, albeit not suffi-
cient to explain the enhanced levels of phospholipase
A2 activity, we exposed permeabilized cells to vaso-
pressin (100 nM) in the presence of 100 FM GTPyS in
order to stimulate phospholipase C. Under these con-
ditions there was a significant increase in 3H-dig-
lyceride (1.55 ± 0.14% of total radioactivity to 2.37 +
0.29%, n = 8, p < 0.01). There was, however, no
increase in free arachidonic acid (22). Thus, under
conditions where phospholipase C and presumably
protein kinase C were activated, there was no stimu-
lation ofphospholipase A2 if[Ca2']f was maintained at
low basal cellular levels.
To establish that this synergistic effect between
Ca2' and PMA that was seen in permeabilized cells
was also present in intact cells, we examined free
arachidonic acid levels in intact cells stimulated with
A23187, PMA, A23187 + PMA, or vasopressin alone
for 10 min (Fig. 3). At low doses of the calcium
ionophore, A23187, 0.1 gM, only a slight increase
occurred in arachidonic acid release. PMA alone had
no effect on arachidonic acid release. In spite of this
small effect of ionophore and no effect of PMA alone,
both added together resulted in a marked stimulation
of arachidonic acid release, reflecting a synergistic
interaction. The levels of free arachidonic acid
reached with the combination of A23187 and PMA in
intact cells equalled that with vasopressin (100 nM)
alone. Using higher concentrations of A23187 (1 gM)
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FIGURE 3. Release of free 3H-arachidonic acid from intact
mesangial cells stimulated for 10 min with the Ca2' ionophore,
A23187; PMA alone; the combination of A23187 and PMA; or
vasopressin. The data bars represent the mean ± 1 SEM of six
to eight experiments. From Bonventre and Swidler (22).
and lower concentrations of PMA (10 nM), and also
longer time periods for stimulation (30 min), the
levels of free arachidonic acid far exceeded that of
vasopressin alone (22).
To demonstrate further that this effect of PMA was
due to an effect of protein kinase C and not a nonspe-
cific effect of phorbol esters, we used the diacylg-
lycerol analogue, 1-oleoyl 2-acetylglycerol. This
analogue also worked synergistically with A23187 to
increase free arachidonic levels in intact mesangial
cells (22).
We concluded from this data that agonist-induced
changes in [Ca2+]f alone were not sufficient to account
for the phospholipase A2 activation observed with
vasopressin. Our data indicate that the stimulation of
protein kinase C enhances the activation of
phospholipase A2. A protein kinase C-dependent phos-
phorylation process may, therefore, be important in
enhancement of acylhydrolase activity in the
mesangial cell. It is possible that protein kinase C
phosphorylates phospholipase A2 itself or proteins
with phospholipase A2 modulatory capability (29). It
has been proposed that a family of proteins, referred
to as lipocortins, may exert a chronic inhibitory influ-
ence on phospholipase A2 that is released when the
compounds are phosphorylated. In collaboration with
Dr. Blake Pepinsky we have identified the presence of
lipocortin I and lipocortin II in mesangial cells (22);
however, there remains considerable controversy as
to whether these proteins represent endogenous func-
tionally important regulated inhibitors of
phospholipase A2 (30). Another possible explanation
for protein kinase C-enhanced phospholipase A2 activ-
ity is that protein kinase C may phosphorylate a
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GTP-binding (G) protein, which interacts with
phospholipase A2 to enhance hydrolase activity when
the latter is stimulated by Ca2'. G-proteins have been
reported to modulate phospholipase A2 activity in rod
outer segments of bovine retina (31) and FRTL-5 rat
thyroid cells (32). Phospholipase A2 in RAW 264.7
macrophages is enhanced by both cholera toxin and
pertussis toxin, suggesting stimulatory and inhibitory
G-protein involvement in the process (33). Finally,
Schlondorff et al. (34) and Pfeilschifler and Bauer
(35) found that pertussis toxin modulated agonist-
induced PGE2 synthesis. Our data, indicating no acti-
vation of phospholipase A2 with GTP-yS under condi-
tions of very low cytosolic calcium concentrations, do
not rule out a potential role for a GTP-binding pro-
tein in phospholipase A2 activation when cytosolic
calcium levels are increased. Protein kinase C may
also activate a Na+/H+ exchange process (36), which
we have identified to be present in the mesangial cell
(37). This in turn may activate phospholipase A2 by a
phospholipase C-independent mechanism, as has been
reported in the platelet (38). This would not however
explain the PMA effect in the permeabilized cell
where the pH was clamped.
Phospholipase C-Independent
Activation of Phospholipase A2
Many agonists that increase phospholipase A2
activity in cells increase phospholipase C activity
promptly upon interaction with their receptors,
resulting in an inability to distinguish a
phospholipase C-dependent activation of
phospholipase A2 mediated by IP3 and an increase in
[Ca2+]f and protein kinase C activity from a potential
phospholipase C-independent mechanism of
phospholipase A2 activation. We were able to dissoci-
ate the two effects for the first time in a nucleated
intact cell preparation by examining phospholipase C
and phospholipase A2 activation patterns in response
to platelet-derived growth factor (PDGF) (39). PDGF
increases [Ca2+]f in mesangial cells. However, in con-
trast to vasopressin and platelet-activating factor
that increased Ca2+ to peak levels in less than 10 sec
of agonist stimulation, PDGF increases [Ca2+]f levels
much more slowly, with the peak response occurring
at 1 min. This slow[Ca2']f activation pattern is seen at
a number of different concentrations of PDGF, rang-
ing from 0.005 units/mL to 5 units/mL. One possible
explanation for this delay in the peak Ca2' response is
that PDGF-induced stimulation of phospholipase C
may also be delayed. As indicated in Figure 4, when
either inositol phosphate or diacylglycerol levels were
determined at 15 sec after PDGF stimulation, there
was no significant increase in phospholipase C activa-
tion. On the other hand, by 2 min there was an
approximately 100% increase in the diacylglycerol
and inositol phosphate levels. By contrast, free
arachidonic levels increased by more than 100%
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FIGURE 4. Time course of changes in cytosolic free Ca2" ([Ca2+]f)
free 3H-arachidonic acid, 3H-diacylglycerol, and inositol
trisphosphate levels in mesangial cells after stimulation with
platelet-derived growth factor (PDGF). [Ca2+]f was measured
using the fluorescent probe, Fura-2. Data redrawn from
Bonventre et al. (39). Figure taken from Bonventre (40).
Reprinted with permission from Raven Press.
within the first 15 sec of PDGF stimulation. This
indicates, therefore, that in response to PDGF there
is a rapid increase in phospholipase A2 that precedes
the peak in Ca2` response. This suggests a Ca2+-inde-
pendent phospholipase C-independent mechanism for
activation of phospholipase A2. This phospholipase C-
independent pathway for phospholipase A2 activation
may involve GTP-binding proteins or may involve
other events within the cell. For example, it is possi-
ble that the Na+/H+ exchange activation that is seen
by some investigators with PDGF in other cell types
(41) may activate phospholipase A2 in the mesangial
cell in a manner that is similar to that postulated in
the platelet (42). Another possible explanation for the
activation of phospholipase A2 might be a change in
membrane potential which has been shown to acti-
vate the enzyme when incorporated into lipid bilayers
(43).
Synergistic Interactions with Calcium
May Mediate Tissue Damage
The effects described above may help to explain
how modest levels of increases in [Ca21]f can mediate
tissue damage by activation ofphospholipase A2, even
though the calcium sensitivity of this enzyme would,
at first glance, argue against the Ca2'-mediated acti-
vation. An example of a Ca2'-mediated detrimental
action on a cell that is mediated by a synergistic
interaction with another type of agonist, in this case,
oxygen free radicals, is the Ca2 , oxygen free radical-
induced synergistic damage seen in renal mitochon-
dria that is, likely, secondary to the activation of
phospholipase A2 (44). With a variety of forms of
ischemic and toxic injury cellular accumulation of
Ca2+ and generation of oxygen free radicals have been
implicated as mediators of cellular damage (9,24).
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Potential damaging effects of these agents on mito-
chondrial function may result in impaired ATPase
synthesis and abnormal cellular bioenergetic pro-
cesses, leading ultimately to cell death. In order to
model in vitro conditions mimicking the mitochon-
drial environment in vivo resulting from exposure of
the cell to toxic and ischemic influences, mitochondria
were exposed to Ca2' and reactive oxygen species gen-
erated by hypoxanthine and xanthine oxidase in the
presence of iron. Ca2+ treatment of mitochondria
alone had no detrimental effects on mitochondria
bioenergetics. By contrast, Ca21 pretreatment fol-
lowed by the exposure to reactive oxygen species
resulted in complete uncoupling of oxidative phospho-
rylation. There was an associated defect in the elec-
tron transport chain when site I substrates were used
(Fig. 5). In addition the site I enzyme, NADH CoQ
reductase, was examined directly and found to be
markedly inhibited in response to Ca2+ and reactive
oxygen species. The F1Fo ATPase and adenine nucleo-
tide translocase activities were also markedly inhib-
ited by Ca2+ and reactive oxygen species. Again, in
each case the reactive oxygen species and Ca2" acted
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synergistically, while Ca2" alone had no adverse effect
on the membranes. Also, in all cases dibucaine, an
inhibitor of phospholipase A2, protected the mito-
chondria either partially or completely against the
adverse effects of Ca2' and reactive oxygen species.
We have postulated one possible model for this syn-
ergistic interaction between Ca2" and phospholipase
A2 (44). Reactive oxygen species may initially increase
the permeability of the mitochondria outer and inner
membranes. Phospholipase A2, located predominantly
in the outer membrane, may be activated by mito-
chondrial Ca21 influx. Lipid peroxidation by reactive
oxygen species may enhance the susceptibility of
these membranes to the action of activated
phospholipase A2 (45). Phospholipase A2 may perme-
ate the inner membrane gaining access to and causing
degradation of the electron transport chain, ATPase,
and translocase. The mitochondrial membrane has a
high content of diphosphatidylglycerol (cardiolipin), a
critical component of the catalytic subunits of the
electron transport chain (17), ATP synthase (18,19)
and adenine nucleotide translocase (20). With its high
concentration of unsaturated fatty acids (46) and its
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FIGURE 5. Effects of hypoxanthine (HX), xanthine oxidase (XO), and Fe in the absence (HXXO) or presence of Ca2" (30 nmole/mg
mitochondrial protein, CaHXXO) on renal cortical mitochondrial function. Calcium alone in these amounts had no effect upon mito-
chondrial function. Hypoxanthine and xanthine oxidase, in the presence of iron, increased mitochondrial membrane H+ permeability to
a modest degree and also moderately impaired FIFO ATPase activity. By contrast, when the mitochondria took up an amount ofCa2"that,
of itself, had no adverse effects upon mitochondrial function, the subsequent exposure to hypoxanthine and xanthine oxidase resulted in
a marked increase in inner membrane permeability, and impairment in electron transport chain site I (NADH CoQ reductase)
enzymatic activity, adenine nucleotide translocase, and FIFO ATPase activities. Dibucaine mitigated the synergistic damaging effects of
reactive oxygen species and Ca2" upon the electron transport chain, adenine nucleotide translocase and FIFO ATPase. [Figure reproduced
with permission from Thuren et al. (43)].
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cone-shaped configuration (21), it may confer particu-
larly high susceptibility of these mitochondrial sites
to the action of phospholipase A2.
Summary
Fundamental to an understanding of the role of
Ca21 in physiological and pathophysiological pro-
cesses, is the understanding of Ca2' homeostasis and
the documentation of changes in [Ca2']f associated
with various cell stimuli. However, in order to deter-
mine how [Ca21]f is involved in a number of physiolog-
ical and toxicological processes, it is important to
take into account the complex interactions between
Ca2 , other second messengers, protein kinases and
other inflammatory mediators. These multiple influ-
ences in the cell may work together synergistically to
activate processes that mediate the physiological
function of the cell agonist or the damaging effects on
intracellular organelles or membranes. An important
cellular enzyme, such as phospholipase A2, which
mediates a variety of normal and abnormal cellular
responses, is not regulated simply by changes in levels
of cytosolic free [Ca2"] alone. The regulation of this
and, probably, other critical cellular effector enzymes
is much more intricate and, at the present time,
incompletely characterized.
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